Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 15 | 2025 | 2646 | 3.330 |
Why?
|
| Breast | 3 | 2021 | 216 | 1.580 |
Why?
|
| Biopsy, Large-Core Needle | 5 | 2025 | 35 | 1.450 |
Why?
|
| Fibrocystic Breast Disease | 2 | 2025 | 7 | 1.430 |
Why?
|
| Apocrine Glands | 2 | 2025 | 5 | 1.430 |
Why?
|
| Papilloma, Intraductal | 2 | 2024 | 5 | 1.410 |
Why?
|
| Carcinoma, Lobular | 2 | 2020 | 25 | 1.260 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2020 | 87 | 1.200 |
Why?
|
| Lymph Nodes | 2 | 2022 | 361 | 1.140 |
Why?
|
| Carcinoma | 4 | 2019 | 281 | 1.050 |
Why?
|
| Biomarkers, Tumor | 7 | 2021 | 1603 | 0.950 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2021 | 69 | 0.860 |
Why?
|
| Triple Negative Breast Neoplasms | 3 | 2025 | 280 | 0.820 |
Why?
|
| Pregnancy Complications, Neoplastic | 2 | 2021 | 61 | 0.800 |
Why?
|
| Sentinel Lymph Node | 1 | 2021 | 9 | 0.710 |
Why?
|
| Cervix Uteri | 1 | 2022 | 55 | 0.710 |
Why?
|
| Pathologists | 1 | 2021 | 27 | 0.710 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2021 | 6 | 0.690 |
Why?
|
| Placenta | 2 | 2022 | 513 | 0.660 |
Why?
|
| CDX2 Transcription Factor | 1 | 2020 | 11 | 0.650 |
Why?
|
| Breast Carcinoma In Situ | 1 | 2020 | 2 | 0.650 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2020 | 18 | 0.650 |
Why?
|
| Carcinoma in Situ | 1 | 2020 | 70 | 0.620 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2020 | 69 | 0.610 |
Why?
|
| Axilla | 1 | 2019 | 43 | 0.600 |
Why?
|
| Immunohistochemistry | 5 | 2023 | 1592 | 0.600 |
Why?
|
| Nevus | 1 | 2019 | 34 | 0.590 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2019 | 10 | 0.590 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 901 | 0.570 |
Why?
|
| Tracheal Neoplasms | 1 | 2018 | 22 | 0.570 |
Why?
|
| Gastrointestinal Tract | 1 | 2020 | 224 | 0.550 |
Why?
|
| Oncogene Proteins | 1 | 2018 | 136 | 0.540 |
Why?
|
| Melanoma | 1 | 2023 | 919 | 0.500 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 1535 | 0.490 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2013 | 96 | 0.480 |
Why?
|
| Female | 28 | 2025 | 70509 | 0.480 |
Why?
|
| Liver | 1 | 2022 | 1802 | 0.430 |
Why?
|
| Fibroma | 1 | 2014 | 29 | 0.420 |
Why?
|
| Ossification, Heterotopic | 1 | 2014 | 36 | 0.420 |
Why?
|
| Paired Box Transcription Factors | 1 | 2014 | 75 | 0.420 |
Why?
|
| CD5 Antigens | 1 | 2014 | 33 | 0.420 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 62 | 0.420 |
Why?
|
| Thymus Neoplasms | 1 | 2014 | 40 | 0.410 |
Why?
|
| Mammary Glands, Human | 1 | 2014 | 81 | 0.410 |
Why?
|
| Precancerous Conditions | 1 | 2016 | 280 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2013 | 78 | 0.390 |
Why?
|
| Hemangioendothelioma, Epithelioid | 1 | 2013 | 10 | 0.390 |
Why?
|
| Humans | 34 | 2025 | 130574 | 0.390 |
Why?
|
| Middle Aged | 14 | 2025 | 28448 | 0.390 |
Why?
|
| Loss of Heterozygosity | 1 | 2013 | 124 | 0.380 |
Why?
|
| Microsatellite Repeats | 1 | 2013 | 210 | 0.370 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1214 | 0.370 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2013 | 177 | 0.360 |
Why?
|
| Diagnosis, Differential | 5 | 2020 | 1892 | 0.350 |
Why?
|
| Mammography | 2 | 2025 | 129 | 0.350 |
Why?
|
| Translocation, Genetic | 1 | 2013 | 347 | 0.340 |
Why?
|
| Meningioma | 1 | 2013 | 139 | 0.340 |
Why?
|
| Meningeal Neoplasms | 1 | 2013 | 210 | 0.330 |
Why?
|
| Transcription Factors | 1 | 2020 | 2440 | 0.330 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2011 | 68 | 0.320 |
Why?
|
| Anemia | 1 | 2013 | 354 | 0.290 |
Why?
|
| Aged | 8 | 2025 | 20925 | 0.290 |
Why?
|
| Biopsy | 3 | 2020 | 1238 | 0.270 |
Why?
|
| Adult | 8 | 2025 | 31202 | 0.250 |
Why?
|
| Neoplasm Proteins | 2 | 2021 | 673 | 0.230 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 5221 | 0.230 |
Why?
|
| India | 5 | 2013 | 244 | 0.220 |
Why?
|
| Mastectomy | 2 | 2021 | 75 | 0.210 |
Why?
|
| Tumor Microenvironment | 2 | 2025 | 690 | 0.200 |
Why?
|
| Leiomyoma | 1 | 2024 | 74 | 0.200 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2024 | 344 | 0.190 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 104 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2024 | 479 | 0.180 |
Why?
|
| Pathology Department, Hospital | 1 | 2021 | 1 | 0.180 |
Why?
|
| Body Composition | 1 | 2024 | 549 | 0.180 |
Why?
|
| Proteogenomics | 1 | 2023 | 110 | 0.180 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2024 | 221 | 0.180 |
Why?
|
| Pelvis | 1 | 2022 | 68 | 0.180 |
Why?
|
| Anoctamin-1 | 1 | 2021 | 3 | 0.170 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 1314 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2021 | 39 | 0.170 |
Why?
|
| GATA3 Transcription Factor | 1 | 2021 | 45 | 0.170 |
Why?
|
| Canada | 1 | 2021 | 326 | 0.170 |
Why?
|
| Embryonic Development | 1 | 2022 | 204 | 0.160 |
Why?
|
| Crystal Arthropathies | 1 | 2020 | 5 | 0.160 |
Why?
|
| Pregnancy | 3 | 2022 | 7492 | 0.160 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 426 | 0.160 |
Why?
|
| Synovial Membrane | 1 | 2020 | 27 | 0.160 |
Why?
|
| Muscle Neoplasms | 1 | 2020 | 21 | 0.160 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2019 | 12 | 0.160 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 317 | 0.160 |
Why?
|
| Kidney Neoplasms | 1 | 2024 | 417 | 0.150 |
Why?
|
| Ultrasonography, Mammary | 1 | 2019 | 31 | 0.150 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 788 | 0.150 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 401 | 0.140 |
Why?
|
| Exophthalmos | 1 | 2018 | 31 | 0.140 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 208 | 0.130 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 701 | 0.130 |
Why?
|
| Orbital Neoplasms | 1 | 2018 | 49 | 0.130 |
Why?
|
| Infant, Newborn | 4 | 2022 | 8553 | 0.130 |
Why?
|
| Orbit | 1 | 2018 | 81 | 0.130 |
Why?
|
| Gout | 1 | 2020 | 172 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 2097 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 732 | 0.120 |
Why?
|
| Bacteria | 1 | 2020 | 538 | 0.120 |
Why?
|
| Vision Disorders | 1 | 2018 | 195 | 0.120 |
Why?
|
| Rotavirus Infections | 2 | 2008 | 283 | 0.120 |
Why?
|
| Gastroenteritis | 2 | 2008 | 308 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 915 | 0.120 |
Why?
|
| Metaplasia | 1 | 2016 | 216 | 0.120 |
Why?
|
| Diagnostic Errors | 1 | 2019 | 342 | 0.120 |
Why?
|
| Cell Movement | 1 | 2019 | 868 | 0.110 |
Why?
|
| Bone Neoplasms | 1 | 2020 | 441 | 0.110 |
Why?
|
| Membrane Transport Proteins | 1 | 2016 | 181 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6773 | 0.110 |
Why?
|
| Microbiota | 1 | 2020 | 444 | 0.110 |
Why?
|
| Rhabdomyosarcoma | 1 | 2018 | 225 | 0.110 |
Why?
|
| Mucinoses | 1 | 2014 | 2 | 0.110 |
Why?
|
| Mitochondrial Turnover | 1 | 2014 | 3 | 0.110 |
Why?
|
| Fibroadenoma | 1 | 2014 | 9 | 0.110 |
Why?
|
| Enzyme Activators | 1 | 2014 | 11 | 0.110 |
Why?
|
| PAX8 Transcription Factor | 1 | 2014 | 14 | 0.110 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2014 | 32 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2016 | 347 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2019 | 972 | 0.100 |
Why?
|
| Young Adult | 2 | 2018 | 9991 | 0.100 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 56 | 0.100 |
Why?
|
| Male | 9 | 2020 | 64557 | 0.100 |
Why?
|
| Cross Reactions | 1 | 2014 | 158 | 0.100 |
Why?
|
| Reperfusion Injury | 1 | 2014 | 108 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2025 | 17653 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2013 | 68 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2013 | 97 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 4034 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2024 | 4665 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 2849 | 0.090 |
Why?
|
| Adolescent | 3 | 2018 | 20774 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2016 | 1017 | 0.090 |
Why?
|
| Bone Marrow | 1 | 2013 | 315 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2013 | 364 | 0.080 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2011 | 20 | 0.080 |
Why?
|
| Craniopharyngioma | 1 | 2011 | 34 | 0.080 |
Why?
|
| Hospitals | 2 | 2011 | 434 | 0.080 |
Why?
|
| Astrocytoma | 1 | 2011 | 105 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2014 | 472 | 0.080 |
Why?
|
| Age Distribution | 1 | 2011 | 426 | 0.080 |
Why?
|
| Ependymoma | 1 | 2011 | 154 | 0.070 |
Why?
|
| Diarrhea | 2 | 2008 | 312 | 0.070 |
Why?
|
| United States | 2 | 2021 | 11820 | 0.070 |
Why?
|
| Nurseries, Hospital | 1 | 2008 | 6 | 0.070 |
Why?
|
| Diarrhea, Infantile | 1 | 2008 | 31 | 0.070 |
Why?
|
| Kidney | 1 | 2014 | 1283 | 0.070 |
Why?
|
| Cryptosporidiosis | 1 | 2007 | 34 | 0.070 |
Why?
|
| Medulloblastoma | 1 | 2011 | 388 | 0.060 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2007 | 133 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1921 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2008 | 291 | 0.060 |
Why?
|
| Infant, Premature, Diseases | 1 | 2008 | 254 | 0.060 |
Why?
|
| Rotavirus | 1 | 2008 | 366 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2008 | 400 | 0.050 |
Why?
|
| Prognosis | 1 | 2013 | 4927 | 0.050 |
Why?
|
| NFI Transcription Factors | 1 | 2023 | 50 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 89 | 0.050 |
Why?
|
| Neurofibromin 1 | 1 | 2023 | 58 | 0.050 |
Why?
|
| Nephrectomy | 1 | 2024 | 157 | 0.050 |
Why?
|
| Hysterectomy | 1 | 2024 | 204 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2024 | 496 | 0.040 |
Why?
|
| Child | 2 | 2013 | 26145 | 0.040 |
Why?
|
| Macrophages | 1 | 2025 | 652 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 731 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2020 | 111 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2021 | 752 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2020 | 125 | 0.040 |
Why?
|
| Hospitalization | 1 | 2008 | 1932 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2014 | 12891 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 616 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 1132 | 0.030 |
Why?
|
| Fundus Oculi | 1 | 2018 | 35 | 0.030 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2019 | 169 | 0.030 |
Why?
|
| Infant | 2 | 2011 | 13306 | 0.030 |
Why?
|
| Fluorescein Angiography | 1 | 2018 | 64 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2011 | 14987 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2023 | 2556 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2025 | 1694 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1456 | 0.030 |
Why?
|
| Endoscopy | 1 | 2018 | 271 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2019 | 435 | 0.030 |
Why?
|
| Retina | 1 | 2018 | 451 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 449 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2014 | 586 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 228 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1136 | 0.020 |
Why?
|
| Disease Progression | 1 | 2018 | 2201 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 517 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 2571 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2014 | 804 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2014 | 796 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 3412 | 0.020 |
Why?
|
| Cryptosporidium | 1 | 2007 | 26 | 0.020 |
Why?
|
| Water | 1 | 2007 | 185 | 0.020 |
Why?
|
| Urban Population | 1 | 2007 | 274 | 0.010 |
Why?
|
| Rural Population | 1 | 2007 | 265 | 0.010 |
Why?
|
| Feces | 1 | 2008 | 722 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 4664 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2008 | 852 | 0.010 |
Why?
|
| Genotype | 1 | 2008 | 2609 | 0.010 |
Why?
|
| Animals | 2 | 2014 | 33899 | 0.010 |
Why?
|
| Risk Factors | 1 | 2007 | 10993 | 0.010 |
Why?
|